2011
DOI: 10.3233/jad-2011-110269 View full text |Buy / Rent full text
|
|

Abstract: β-secretase, a key enzyme involved in amyloid-β generation, is an attractive candidate for Alzheimer's disease therapy. Transition-state inhibitors of β-secretase are designed to achieve specificity. However, these inhibitors bind only to the active conformation of the enzyme and as the active β-secretase is sequestered in subcellular compartments, new strategies have to be implemented. We propose that membrane-anchoring of β-secretase inhibitors would render them endocytosis-competent thereby enabling the inh… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
2
5
0

Publication Types

Select...

Relationship

0
0

Authors

Journals